The Recent Concept of Heart Function in Elderly Patients

An epidemic increase in heart failure (HF) mortality, hospitalization, and prevalence rates has been observed among older persons associated with increased an incidence and improved survival in recent years, in spite of a decrease in coronary artery and cerebrovascular disease mortality. Importantly, increases in HF mortality and morbidity rates were confi ned to the population over 65 years of age in the Framingham study. In contrast to middle-aged patients with HF, factors other than left ventricular (LV) systolic dysfunction contribute to HF in older patients. Epidemiological studies have established that 40 to 80 percent of older patients with heart failure, despite preserved ejection fraction without valve disease, are attributed to LV diastolic dysfunction. Keyword: geriatrics, elderly person, diastolic heart function, heart failure Introduction increase in heart failure (HF) mortality, hospitalization, and prevalence rates has been observed among older persons associated with an increased incidence and improved survival in recent years, in spite of a decrease in coronary artery and cerebrovascular disease mortality. 1 Importantly, increases in HF mortality and morbidity rates were confi ned to the population over 65 years of age in the Framingham study. 2 In contrast to middle-aged patients with HF, factors other than left ventricular (LV) systolic dysfunction contribute to HF in older patients. Epidemiological studies have established that 40 to 80 percent of older patients with heart failure, despite preserved ejection fraction without valve disease, are attributed to LV diastolic dysfunction. That is defi ned as diastolic heart failure (DHF). 3 Studies examining prevalence of diastolic heart failure in hospitalized patients or in patients undergo- ing outpatient diagnostic screening and prospective community based studies have shown that in patients greater than 70 years old, the prevalence of diastolic heart failure approaches 50%. 4-6 Although HF patients with preserved systolic function have a slightly better prognosis than HF patients with abnor- mal systolic function, there is a fourfold higher mortality risk compared with subjects free of HF. 7

[1]  Ali Ahmed,et al.  Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. , 2007, The American journal of cardiology.

[2]  Ali Ahmed,et al.  Effects of Digoxin on Morbidity and Mortality in Diastolic Heart Failure: The Ancillary Digitalis Investigation Group Trial , 2006, Circulation.

[3]  Stephen S. Cha,et al.  Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence , 2006, Circulation.

[4]  D. Tepper,et al.  Changing Incidence and Survival for Heart Failure , 2006 .

[5]  Wolfgang A Linke,et al.  Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure , 2006, Circulation.

[6]  P. Poole‐Wilson,et al.  Effects of nebivolol in elderly heart failure patients with or without systolic left ventricular dysfunction: results of the SENIORS echocardiographic substudy. , 2006, European heart journal.

[7]  J. Mullooly,et al.  Changing Incidence and Survival for Heart Failure in a Well-Defined Older Population, 1970–1974 and 1990–1994 , 2006, Circulation.

[8]  N. Freemantle,et al.  Perindopril for elderly people with chronic heart failure: the PEP‐CHF study , 1999, European heart journal.

[9]  B. Levine,et al.  Abnormalities of Doppler Measures of Diastolic Function in the Healthy Elderly Are Not Related to Alterations of Left Atrial Pressure , 2005, Circulation.

[10]  A. Cohen-Solal,et al.  Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). , 2005, European heart journal.

[11]  M. Redfield Understanding "diastolic" heart failure. , 2004, The New England journal of medicine.

[12]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[13]  T. Katagiri,et al.  Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons. , 2003, The American journal of medicine.

[14]  Douglas W Mahoney,et al.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. , 2003, JAMA.

[15]  D. Brutsaert,et al.  New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. , 2002, Circulation.

[16]  J. Gardin,et al.  Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the cardiovascular health study. , 2001, Journal of the American College of Cardiology.

[17]  J. Gardin,et al.  Importance of heart failure with preserved systolic function in patients ≥65 years of age , 2001 .

[18]  J. Gardin,et al.  Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. , 2001, The American journal of cardiology.

[19]  J. Gardin,et al.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. , 2000, Journal of the American College of Cardiology.

[20]  W. Abraham,et al.  Hormones and hemodynamics in heart failure. , 1999, The New England journal of medicine.

[21]  D. Levy,et al.  Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. , 1999, Journal of the American College of Cardiology.

[22]  E. Braunwald Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. , 1997, The New England journal of medicine.